Imho.
Stability and established relationship are crucial.
PH should stay. LC is key to success.
Renumeration and performance bonus criteria should be reviewed.
we did not hire any of them. We invest our hard earned and get a vote. We did not do anything to advance the IPs.
Greed is not limited to PH. Big claim I know. But I cannot exclude it from my own motivation.
BP would view disunity and instability as a big weakness and use to their advantage.
not sure how dealings with fda would be affected as well as cooperation from hospitals, as I am sure we get competitions for trial patients from other biotech as well.
IMU does not exist in a bubble in the bio tech world.
imho.
Ann: Notice of Annual General Meeting/Proxy Form, page-224
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |